OPKO Health, Inc. (OPK) stock
OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/3020% below fair value
$1.68+0.01 (+0.60%)
Close on Nov 13, 2026Market cap $1.25BP/E –Yield –
OPKO Health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
OPKO Health's ebitda for the twelve months ending Sep 30, 2026 was -$1.97M. For fiscal 2025 it was -$25.78M. The highest annual figure on record is $143.08M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$25.78M | – |
| FY2024 | Dec 31, 2024 | -$53.89M | – |
| FY2023 | Dec 31, 2023 | -$51.72M | – |
| FY2022 | Dec 31, 2022 | -$117.60M | -220.7% |
| FY2021 | Dec 31, 2021 | $97.47M | -31.9% |
| FY2020 | Dec 31, 2020 | $143.08M | – |
| FY2019 | Dec 31, 2019 | -$180.25M | – |
| FY2018 | Dec 31, 2018 | -$73.85M | – |
| FY2017 | Dec 31, 2017 | -$174.35M | -697496.0% |
| FY2016 | Dec 31, 2016 | $25.00K | – |
| FY2015 | Dec 31, 2015 | -$56.23M | – |
| FY2014 | Dec 31, 2014 | -$130.89M | – |
| FY2013 | Dec 31, 2013 | -$64.42M | – |
| FY2012 | Dec 31, 2012 | -$27.11M | – |
| FY2011 | Dec 31, 2011 | -$19.36M | – |
| FY2010 | Dec 31, 2010 | -$8.93M | – |
| FY2009 | Dec 31, 2009 | -$21.58M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$12.47M | – |
| Q2 FY2026 | Jun 30, 2026 | $15.44M | – |
| Q1 FY2026 | Mar 31, 2026 | -$28.82M | – |
| Q4 FY2025 | Dec 31, 2025 | $23.88M | – |
| Q3 FY2025 | Sep 30, 2025 | -$15.51M | – |
| Q2 FY2025 | Jun 30, 2025 | -$36.95M | – |
| Q1 FY2025 | Mar 31, 2025 | -$43.68M | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.10M | – |
| Q3 FY2024 | Sep 30, 2024 | -$43.01M | – |
| Q2 FY2024 | Jun 30, 2024 | -$37.52M | -212.3% |
| Q1 FY2024 | Mar 31, 2024 | -$45.65M | – |
| Q4 FY2023 | Dec 31, 2023 | -$43.06M | – |
| Q3 FY2023 | Sep 30, 2023 | -$38.22M | – |
| Q2 FY2023 | Jun 30, 2023 | $33.42M | +93.6% |
| Q1 FY2023 | Mar 31, 2023 | -$4.15M | – |
| Q4 FY2022 | Dec 31, 2022 | -$28.81M | – |
| Q3 FY2022 | Sep 30, 2022 | -$59.83M | -205.3% |
| Q2 FY2022 | Jun 30, 2022 | $17.26M | -34.0% |
| Q1 FY2022 | Mar 31, 2022 | -$44.61M | -176.4% |
| Q4 FY2021 | Dec 31, 2021 | -$43.89M | -163.2% |
| Q3 FY2021 | Sep 30, 2021 | $56.79M | +32.1% |
| Q2 FY2021 | Jun 30, 2021 | $26.14M | -47.1% |
| Q1 FY2021 | Mar 31, 2021 | $58.43M | – |
| Q4 FY2020 | Dec 31, 2020 | $69.42M | – |
| Q3 FY2020 | Sep 30, 2020 | $42.98M | – |
| Q2 FY2020 | Jun 30, 2020 | $49.45M | – |
| Q1 FY2020 | Mar 31, 2020 | -$18.71M | – |
| Q4 FY2019 | Dec 31, 2019 | -$89.94M | – |
| Q3 FY2019 | Sep 30, 2019 | -$15.21M | – |
| Q2 FY2019 | Jun 30, 2019 | -$23.60M | -220.1% |
| Q1 FY2019 | Mar 31, 2019 | -$51.50M | – |
| Q4 FY2018 | Dec 31, 2018 | -$66.11M | – |
| Q3 FY2018 | Sep 30, 2018 | -$9.54M | – |
| Q2 FY2018 | Jun 30, 2018 | $19.65M | – |
| Q1 FY2018 | Mar 31, 2018 | -$17.85M | – |
| Q4 FY2017 | Dec 31, 2017 | -$132.22M | – |
| Q3 FY2017 | Sep 30, 2017 | -$22.37M | – |
| Q2 FY2017 | Jun 30, 2017 | -$280.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$19.49M | – |
| Q4 FY2016 | Dec 31, 2016 | -$49.71M | – |
See a number that looks wrong?